Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single cell resolution
- Universidad de Navarra, Spain
- Clinica Universidad de Navarra, Spain
- Hospital Universitario de Salamanca, Spain
- Vall d'Hebron Hospital Universitari, Spain
- NavarraBiomed, Spain
Abstract
Early hematopoiesis is a continuous process in which hematopoietic stem and progenitor cells (HSPCs) gradually differentiate toward specific lineages. Aging and myeloid malignant transformation are characterized by changes in the composition and regulation of HSPCs. In this study, we used single cell RNA sequencing (scRNAseq) to characterize an enriched population of human hematopoietic stem and progenitor cells (HSPCs) obtained from young and elderly healthy individuals. Based on their transcriptional profile, we identified changes in the proportions of progenitor compartments during aging, and differences in their functionality, as evidenced by gene set enrichment analysis. Trajectory inference revealed that altered gene expression dynamics accompanied cell differentiation, which could explain age-associated changes in hematopoiesis. Next, we focused on key regulators of transcription by constructing gene regulatory networks and detected regulons that were specifically active in elderly individuals. Using previous findings in healthy cells as a reference, we analyzed scRNA-seq data obtained from patients with myelodysplastic syndrome (MDS) and detected specific alterations of the expression dynamics of genes involved in erythroid differentiation in all patients with MDS such as TRIB2. In addition, the comparison between transcriptional programs and gene regulatory networks (GRN) regulating normal HSPCs and MDS HSPCs allowed identification of regulons that were specifically active in MDS cases such as SMAD1, HOXA6, POU2F2 and RUNX1 suggesting a role of these TF in the pathogenesis of the disease. In summary, we demonstrate that the combination of single cell technologies with computational analysis tools enable the study of a variety of cellular mechanisms involved in complex biological systems such as early hematopoiesis and can be used to dissect perturbed differentiation trajectories associated with perturbations such as aging and malignant transformation. Furthermore, the identification of abnormal regulatory mechanisms associated with myeloid malignancies could be exploited for personalized therapeutic approaches in individual patients.
Data availability
All the single cell RNA sequencing data is available at Gene Expression Omnibus under accession number GSE180298. The scripts needed to replicate the analysis are deposited on GitHub:https://github.com/mainciburu/scRNA-Hematopoiesis
-
Single-cell, multi-omic analysis identifies regulatory programs in mixed phenotype acute leukemiaNCBI Gene Expression Omnibus, GSE139369.
Article and author information
Author details
Tamara Jiménez Solas
Funding
Instituto de Salud Carlos III
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Ministerio de Ciencia e Innovación (PhD fellowship FPU18/05488)
- Marina Ainciburu
Fundación Científica Asociación Española Contra el Cáncer (Investigador AECC award)
- Teresa Ezponda
H2020 Marie Skłodowska-Curie Actions (Grant Agreement No. 898356)
- Mikel Hernaez
Federación Española de Enfermedades Raras (PI17/00701,PI19/00726 and PI20/01308)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Centro de Investigación Biomédica en Red de Cáncer (CB16/12/00489 and CB16/12/00225)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Gobierno de Navarra (ERAPerMed MEET-AML 0011-2750-2019-000001; AGATA 0011-1411-2020-000010/0011-1411-2020-000011 and DIAN)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
la Caixa" Foundation " (GR-NET NORMAL-HIT HR20-00871)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Cancer Research UK (C355/A26819)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Fundación Científica Asociación Española Contra el Cáncer (Accelerator Award Program)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Associazione Italiana per la Ricerca sul Cancro (Accelerator Award Program)
- Marina Ainciburu
- Teresa Ezponda
- Nerea Berastegui
- Ana Alfonso-Pierola
- Amaia Vilas-Zornoza
- Patxi San Martin-Uriz
- Diego Alignani
- Jose Lamo de Espinosa
- Mikel San Julian
- Tamara Jiménez Solas
- Felix Lopez
- Sandra Muntion
- Fermin Sanchez-Guijo
- Antonieta Molero
- Julia Montoro
- Guillermo Serrano
- Aintzane Diaz-Mazkiaran
- Miren Lasaga
- David Gomez-Cabrero
- Maria Diez-Campelo
- David Valcarcel
- Mikel Hernaez
- Juan Pablo Romero
- Felipe Prosper
Gobierno de Navarra (PhD fellowship 0011-0537-2019-000001)
- Nerea Berastegui
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The samples and data from the patients included in the study were provided by the Biobank of the University of Navarra and were processed according to standard operating procedures. Patients and healthy donors provided informed consent, together with consent for publication. The study was approved by the Clinical Research Ethics Committee of the Clinica Universidad de Navarra, following protocol # 2017.218.
Copyright
© 2023, Ainciburu et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,186
- views
-
- 575
- downloads
-
- 25
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single cell resolution
eLife 12:e79363.
https://doi.org/10.7554/eLife.79363
Further reading
-
- Computational and Systems Biology
The RAS-MAPK system plays an important role in regulating various cellular processes, including growth, differentiation, apoptosis, and transformation. Dysregulation of this system has been implicated in genetic diseases and cancers affecting diverse tissues. To better understand the regulation of this system, we employed information flow analysis based on transfer entropy (TE) between the activation dynamics of two key elements in cells stimulated with EGF: SOS, a guanine nucleotide exchanger for the small GTPase RAS, and RAF, a RAS effector serine/threonine kinase. TE analysis allows for model-free assessment of the timing, direction, and strength of the information flow regulating the system response. We detected significant amounts of TE in both directions between SOS and RAF, indicating feedback regulation. Importantly, the amount of TE did not simply follow the input dose or the intensity of the causal reaction, demonstrating the uniqueness of TE. TE analysis proposed regulatory networks containing multiple tracks and feedback loops and revealed temporal switching in the reaction pathway primarily responsible for reaction control. This proposal was confirmed by the effects of an MEK inhibitor on TE. Furthermore, TE analysis identified the functional disorder of a SOS mutation associated with Noonan syndrome, a human genetic disease, of which the pathogenic mechanism has not been precisely known yet. TE assessment holds significant promise as a model-free analysis method of reaction networks in molecular pharmacology and pathology.
-
- Computational and Systems Biology
- Genetics and Genomics
Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.
